Experimental model of congenital adrenal cortical hyperplasia produced in utero with an inhibitor of 11-beta-steroid hydroxylase.
D000311:Adrenal Glands / Q000201:enzymology; D000312:Adrenal Hyperplasia, Congenital / Q000139:chemically induced*; D000324:Adrenocorticotropic Hormone / Q000502:physiology; D000818:Animals; D003345:Corticosterone / Q000097:blood; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D005333:Fetus / Q000187:drug effects; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006651:Histocytochemistry; D008431:Maternal-Fetal Exchange; D008661:Metabolism, Inborn Errors; D008797:Metyrapone; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D008954:Models, Biological; D009249:NADP / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal; D051381:Rats
D009249:NADP; D000324:Adrenocorticotropic Hormone; D006899:Mixed Function Oxygenases; D005954:Glucosephosphate Dehydrogenase; D003345:Corticosterone; D008797:Metyrapone